Panacea Biotec Files FY26 BRSR Report
Panacea Biotec Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as per SEBI regulations. The company is voluntarily complying with BRSR provisions, even though it may not fall within the top 1000 listed entities by market capitalization. The report details corporate identity, business activities primarily in pharmaceuticals (100% turnover), markets served (including ~37 countries internationally), and workforce representation. Exports contributed approximately 65% of the total turnover for the reporting year. The company supplies vaccines to multilateral agencies like UNICEF and PAHO, alongside institutional and private market customers.
Key Highlights
- Panacea Biotec files FY26 Business Responsibility and Sustainability Report.
- Company voluntarily complies with SEBI's BRSR regulations.
- Pharmaceuticals account for 100% of the entity's turnover.
- Exports represent approximately 65% of the total turnover.
- Supplies vaccines to UNICEF, PAHO, and national governments.
Price Impact
More from PANACEABIO